Cartalax 20 mg

What is Cartalax?

Cartalax (AED Peptide / T-31) is a short peptide bioregulator composed of only three amino acids:

Alanine – Glutamate – Aspartate (Ala-Glu-Asp / AED)

Cartalax has been studied in relation to cartilage, joints, connective tissue, and cellular regulatory processes, particularly cells involved in maintaining the structure of cartilage and connective tissues.

Key Features of Cartalax

Cartalax has been studied for its potential role in supporting:

• Cartilage and joint health

• Maintenance of connective tissue structure

• Cellular repair and regeneration processes

• Chondrocyte function

• Regulation of cell proliferation and apoptosis

• Cellular processes associated with aging

How Does Cartalax Work?

Cartalax does not act directly like a pain reliever or anti-inflammatory medication. Instead, it has been studied as a bioregulatory peptide that may play a role in regulating cellular processes.

Cell-based studies have investigated the relationship between Cartalax and cellular markers such as Ki-67 and p53, which are involved in cell proliferation, survival, and apoptosis.

This class of peptides has also been studied for its potential influence on gene expression and epigenetic regulation, mechanisms associated with cellular function and age-related changes.

Cartilage & Joint Support

Cartilage Support

Cartalax has been studied in relation to chondrocytes, the specialized cells responsible for producing and maintaining cartilage structure.

Connective Tissue Support

It may support biological processes involved in maintai